DUBLIN, Jan. 3, 2023 /PRNewswire/ — The “Pharmaceutical Drugs Industry: Global Competitive Landscape 2021” report has been added to ResearchAndMarkets.com’s offering.
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021.
Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.
71 data tables and 54 additional tables
A brief general overview of the global pharmaceutical drugs industry competitive landscape
Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila
This report discusses the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well-researched and analyzed in this report.
Study Goals and Objectives:
The goals and objectives of this study include:
Defining and discussing the competitive landscape of the global pharmaceutical drugs market in 2021.
Competitive ranking of the top fifty pharmaceutical companies in the market
Profiling major players and analyzing market share, core competencies and strategies in the pharmaceutical drugs market.
Tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market.
Reasons for Doing This Study
With long life expectancy and emerging economies increasing their expenditure on healthcare, there is an increased demand for technologically superior pharmaceutical drugs. More stringent regulations, specifically in the mature markets of the U.S. and Europe, compel pharmaceutical manufacturers to launch sophisticated drugs that incorporate new materials, focus on in-depth indications and generate additional new data.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Market and Technology Background
2.1 Background and Definitions: Pharmaceutical Drugs
2.2 Uses of Various Drugs
2.3 Background: Innovation in the Pharmaceutical Industry
2.4 Stakeholders Involved in the Innovation Process
2.5 the Pharmaceutical Industry
2.6 the Cost of Pharmaceutical Drug Innovation
2.7 Current Trends in the Pharmaceuticals Industry
2.7.1 Digital Transformation and Technological Developments
2.7.2 Increasing R&D Spend and Shift Toward Modern Therapeutics and Technologies
2.7.3 Collaborations for Advanced Therapeutics
2.7.4 Market Consolidation for Strategic Growth and to Retain Market Leadership
2.8 Notable Trends
2.8.1 Income Growth in Developing Markets
2.8.2 Changing Structure of the Pharma and Healthcare Industry
2.8.3 Lifestyle Medicine
2.8.4 Patient-Centric Programs
2.8.5 Prevalence of Self-Care
2.8.6 Burden on Public Health System
2.9 Importance of Innovation
2.10 Challenges Facing the Sector
2.10.1 Public Health Systems
2.10.2 Balancing Patient Needs and Financial Sustainability
2.10.3 Competitiveness and Innovation
2.11 Market Dynamics
2.14 Distribution Network
2.14.7 South Korea
Chapter 3 Impact of Covid-19 on the Pharmaceutical Drug Market
3.2 Covid-19 Crisis
3.3 Impact on Market
3.4 Current Outlook
3.4.1 Implications on Cancer Diagnosis
3.4.2 Implications on Cancer Treatment
3.4.3 Impact on Oncology Pharmaceuticals Market
3.5 Implications on Cancer Treatment
3.5.1 Key Impacts of Covid-19
Chapter 4 Regulatory Structure: Pharmaceutical Drug Market
4.1 Regulatory Background
4.2 Regulatory Systems for Biopharmaceuticals by Region
4.3 Regulatory Systems for Pharmaceuticals by Region
4.4 Regulations for Vaccines
4.4.1 Current Regulatory Issues for Vaccines
4.4.2 Moderna Vaccine Regulation in the U.K.
4.5 Key Regulatory Updates, 2020
4.5.2 Medical Devices
4.6 Code of Federal Regulations (Cfr)
4.7 Good Manufacturing Compliance (Gmp) Compliance
4.8 Establishment Registration
4.9 Drug Registration and Listing
4.10 Local Agent Requirements
4.10.1 Responsibilities of the U.S. Agent
Chapter 5 Pricing and Reimbursement: Pharmaceuticals and Biologics
5.1 Pricing and Reimbursement Background
5.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
5.3 Pricing and Reimbursement Challenges for Pharmaceuticals
5.3.1 Patented Medicines Price
5.3.2 Prices of Older Drugs
5.4 Pricing and Reimbursement for Medical Devices by Region
5.5 Other Parts of Asia-Pacific
Chapter 6 Pharmaceutical Drugs Industry: Competitive Landscape
6.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers
6.2.1 Distribution Network
6.2.3 Mergers and Acquisitions
6.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers
6.3.1 Mergers and Acquisitions in Pharmaceutical Drugs Market
6.3.2 Agreements, Joint Ventures, Expansions, Divestments and Investments, Pharmaceuticals Market
6.3.4 New Product Launches and Approvals
6.4 Long-Term Outlook
Chapter 7 Company Profiles
Alexion Pharmaceuticals Inc.
Astellas Pharma Inc.
Asahi Kasei Corp.
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Company
Chugai Pharmaceutical Co. Ltd.
Daiichi Sankyo Co. Ltd.
Dr. Reddy’s Laboratories Ltd.
Eisai Co. Ltd.
Eli Lilly and Co.
Endo International plc
Gilead Sciences Inc.
H. Lundbeck A/S
Johnson & Johnson Services Inc.
A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Merck & Co. Inc.
Novo Nordisk A/S
Otsuka Holdings Co. Ltd.
Regeneron Pharmaceuticals Inc.
F. Hoffmann-La Roche Ltd. (Roche)
Shanghai Pharmaceuticals Holding
Shionogi & Co. Ltd.
China National Pharmaceutical Group Corp. (Sinopharm)
Stada Arzneimittel AG
Sumitomo Pharma Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Inc.
For more information about this report visit https://www.researchandmarkets.com/r/xwh7mj
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/outlook-on-the-pharmaceutical-drugs-global-market-to-2027-look-at-the-changing-structure-of-the-pharma-and-healthcare-industry-301712225.html
SOURCE Research and Markets